Rodriguez Javier 4
4 · BioXcel Therapeutics, Inc. · Filed Mar 17, 2025
Insider Transaction Report
Form 4
Rodriguez Javier
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2025-03-15+34→ 1,591 total - Exercise/Conversion
Common Stock
2025-03-14+31→ 1,557 total - Exercise/Conversion
Restricted Stock Units
2025-03-15−34→ 387 total→ Common Stock (34 underlying) - Exercise/Conversion
Restricted Stock Units
2025-03-14−31→ 229 total→ Common Stock (31 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]On March 14, 2022, the Reporting Person was granted 521 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
- [F3]On March 15, 2023, the Reporting Person was granted 562 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 15, 2023 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.